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Edited by Ulf-Ingo Flu¨ggeAbstract The inhibitory properties of a ﬁrst synthetic jasmonic
acid biosynthesis inhibitor, JM-8686, were investigated. Steady-
state kinetic analysis indicates that the compound is a competi-
tive inhibitor of allene oxide synthase (AOS) with a Ki value
of approximate 0.62 ± 0.15 lM. Dialysis experiment indicates
that AOS inactivation by JM-8686 is reversible. The optical dif-
ference spectroscopy analysis of JM-8686 and AOS interaction
indicates that JM-8686 induced type II binding spectra with a Kd
value of approximate 1.6 ± 0.2 lM, suggesting that JM-8686
binds to the prosthetic heme iron of AOS. Comparison of the
inhibitory potency of the compound against HPL (CYP74B)
from tomato revealed that JM-8686 was a highly selective inhib-
itor for AOS.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Inhibitor1. Introduction
Oxidative metabolism of unsaturated fatty acids in plants
leads to the production of a group of bioactive phyto-oxylipins
[1]. Jasmonic acid (JA) and methyl jasmonate (MeJA), collec-
tively referred to as jasmonates (JAs), are end products of the
phytooxylipin biosynthetic cascade. JAs are important signals
for the regulation of gene expression in response to stress and
developmental cues. JAs have been well characterized with re-
spect to their role in defense against herbivore attack and
infection by some pathogens [2]. JAs also are implicated in
the control of plant responses to abiotic stimuli such as
mechanical stress [3], salt stress and UV irradiation [4,5]. Exog-
enous JAs exert numerous inductive and inhibitory eﬀects onAbbreviations: JM-8686, 8-[1-(2,4-dichloro-phenyl)-2-imidazol-1-yl-
ethoxy]-octanoic acid heptyl ester; AOS, allene oxide synthase; AtA-
OS, Arabidopsis thaliana allene oxide synthase; HPL, fatty acid
hydroperoxide lyase; LeHPL, Lycopersicon esculentum fatty acid
hydroperoxide lyase; DES, divinyl ether synthase; 13 (S) HPOT, 13
(S)-hydroperxy-9 (Z), 11 (E), 15 (Z)-octadecatrienoic acid; JAs,
Jasmonates; JA, jasmonic acid
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doi:10.1016/j.febslet.2006.09.044plant developmental processes [6]. Correlations between
endogenous jasmonate levels in speciﬁc tissues and the eﬀects
of the applied hormone have provided evidence that JAs have
a role in fruit ripening, embryo development [6], senescence [7]
and the accumulation of storage proteins [8]. The analysis of
JA-deﬁcient mutants of Arabidopsis has provided evidence that
JAs play a key role in ﬂower development. The critical require-
ment of JAs in male fertility was established by the character-
ization of an Arabidopsis mutant that fails to produce linolenic
acid, the fatty acid precursor of JA [9]. Subsequently, muta-
tions that disrupt other steps in the JA biosynthetic pathway
were also shown to cause male sterility [10].
The importance of JAs in the plant life cycle has promoted
increasing interest in understanding the mechanisms by which
JA biosynthesis is regulated [6]. JA accumulation is stimulated
by mechanical wounding and herbivory [11], as well as by
pathogen attack and chemical elicitors [12]. Recent studies
indicate that allene oxide synthase (AOS), which catalyzes
the ﬁrst reaction in the speciﬁc pathway of JA biosynthesis,
is an important site of regulation. AOS expression is positively
regulated by wounding [13], and transgenic studies suggest that
over-expression of AOS might be a way of controlling defense
dynamics in higher plants [14]. Mutations that disrupt AOS
function in Arabidopsis cause male sterility and reduce re-
sponses of leaves to mechanical wounding [10], indicating that
AOS is an important site for controlling the JA biosynthesis.
Thus, development of new tools for regulation of JA bio-
synthesis may be valuable for dissecting JA-related signal
transduction networks. An alternative way to control JA bio-
synthesis is the use of speciﬁc inhibitors that target important
enzymes of JA biosynthesis. Available evidence indicates that
AOS is a potential target for design of speciﬁc inhibitors of
JA biosynthesis.
Biochemical and molecular studies have shown that AOS is a
cytochrome P450 enzyme [15]. Strategies to design P450 inhibi-
tors may thus be applied to the identiﬁcation of AOS inhibitors.
The inhibition mechanism of the cytochrome P450 enzyme has
been studied in considerable detail [16]. It is known that imida-
zole derivatives have widespread ability P450 inhibitors, appar-
ently due to the intrinsic aﬃnity of the nitrogen electron pair in
heterocyclic molecules for the prosthetic heme iron. The
imidazoles thus bind not only to lipophilic regions of the protein
but also simultaneously bind to the prosthetic heme iron [17].
We have previously shown that 8-[1-(2, 4-dichloro-phenyl)-
2-imidazol-1-yl- ethoxy]-octanoic acid heptyl ester (JM-8686,ation of European Biochemical Societies.
Fig. 1. Chemical structure of JM-8686.
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ies [18]. In the present study, we used puriﬁed recombinant
AOS from Arabidopsis to (1) study the kinetics of inhibition
by JM-8686, (2) to determine the binding aﬃnity of JM-8686
to AOS, (3) to investigate the selectivity of JM-8686 by evalu-
ating its inhibitory activity against hydroperoxide lyase (HPL,
CYP74B) from tomato, a subfamily member of CYP74s [19].
The results suggest that JM-8686 is a selective and speciﬁc
inhibitor of AOS. The potential application of AOS inhibitors
in jasmonate research is discussed.2. Materials and methods
2.1. Materials
Ampicillin and isopropyl-b-D-thiogalactopyranoside was purchased
from Wako Pure Chemical Industries, Ltd. (Tokyo, Japan). Linolenic
acid and soybean lipoxygenase was obtained from Sigma–Aldrich
Japan K.K. (Tokyo, Japan). Other reagents of the highest quality are
purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan).
2.2. Inhibitor
JM-8686, 8-[1-(2, 4-dichloro- phenyl)-2-imidazol-1-yl-ethoxy]-octa-
noic acid heptyl ester used in this study was synthesized and puriﬁed
according to the method described previously [18]. The stock solution
of racemates JM-8686 was dissolved in methanol. In all assays for
determination of the AtAOS activity, the amount of methanol was
kept to <1% of the total volume.
2.3. Preparation of 13 (S)-hydroperxy-9(Z), 11(E),
15(Z)-octadecatrienoic acid
13 (S) HPOT was prepared according to a method as described pre-
viously, to establish the absorption coeﬃcient [18]. The stock solution
of 13 (S) HPOT was prepared by dissolving 13 (S) HPOT in methanol
(10 mM) and stored at 80 C.
2.4. Expression and puriﬁcation of recombinant AtAOS
The coding region of AtAOS cDNA that was restricted by the en-
zymes BamHI and KpnI, was inserted into an Escherichia coli expres-
sion vector pQE30 (Qiagen). E. coli M15, transformed with this
construct, was kindly provided by Prof. E. W. Weiler, Lehrstuhl fu¨r
Pﬂanzenphysiologie, Fakulta¨t fu¨r Biologie Ruhr-Universita¨t, Ger-
many. Expression and puriﬁcation of recombinant AtAOS was per-
formed as described previously [18]. The puriﬁed AtAOS was
dialyzed for 24 h at 4 C by using an oscillatory dialysis system (Daii-
chi Pure Chemicals, Co. Ltd. Tokyo, Japan) against 2 · 300 mL dialy-
sis buﬀer (50 mM sodium phosphate buﬀer, pH 7.0). Protein
measurements were performed using a Protein Assay Kit (Bio-Rad,
Herculs, CA, USA) and bovine serum albumin as a standard. The rel-
ative purity of recombinant AtAOS was estimated by SDS–polyacryl-
amide gel electrophoresis (12% polyacrylamide) and staining of gels
with Coomassie Brillant Blue R250.
2.5. Expression and puriﬁcation of recombinant tomato LeHPL
A region of LeHPL cDNA from the EcoRI site just downstream of
the initiation codon to the HindIII site 30 bp downstream of the stop
codon was inserted into the E. coli expression vector, pQE31(QIA-
GEN). M15 was transformed with this construct. An overnight culture
(15 ml) of the cells was added to 300 ml of fresh Turia-Bertani mediumsupplemented with ampicillin (100 lg/mL) and kanamycin (25 mg/ml),
placed in 1-l culture ﬂasks. Bacteria were grown at 37 C in a shaker at
150 rpm to an OD600 of 0.5. Cultures were cooled to 16 C, and isopro-
pyl-b-D-thiogalactopyranoside was added to a ﬁnal concentration of
1 mM. Induced cultures were incubated for 24 h at 16 C with gentle
shaking (100 rmp). Cells were collected by centrifugation. Puriﬁcation
of recombinant LeHPL, protein measurements and the purity of re-
combinant LeHPL was carried out as described above.
2.6. In vitro assays for AtAOS and LeHPL
Enzyme reaction mixture contained 50 mM sodium phosphate buf-
fer pH 7.0, 0.1% Tween 20, enzyme (AtAOS, 5 nM or LeHPL
5 nM), and designed concentrations of substrate (13 (S) HPOT) at
25 C. Activity was measured by following the decrease in absorption
at 235 nm using a Shimadzu UV3100 spectrophotometer (Shimadzu,
Kyoto Japan). An absorption coeﬃcient of 22.8 mM1 cm1was used.
The time course was followed for 400 s to estimate the activity. For
kinetics studies of JM-8686 inhibition, AOS assay was carried out in
triplicate in the presence of varying concentration of JM-8686 and sub-
strate. Enzyme reaction was started by adding AtAOS to a ﬁnal con-
centration of 5 nM.
2.7. Reversibility of AtAOS inactivation by JM-8686
Two samples (2 ml each) contain 15 nM AtAOS in assay buﬀer were
incubated in the absence and in the presence of 5 lM JM-8686 at
25 C. The AtAOS activity was measured as described above to deter-
mine the inhibitory activity of JM-8686 against AtAOS, and then dia-
lyzed separately for 24 h at 4 C against 2 · 300 mL dialysis buﬀer
(50 mM sodium phosphate buﬀer, pH 7.0). After dialysis, the AtAOS
activity of the samples was re-measured to determine the recovery of
AtAOS activity.
2.8. Binding assay of JM-8686 to recombinant AtAOS
Binding of JM-8686 to the AtAOS was measured by optical diﬀer-
ence spectroscopy of puriﬁed recombinant AtAOS using a Shimadzu
UV3100 spectrophotometer. Puriﬁed recombinant AtAOS was diluted
in 50 mM sodium phosphate buﬀer (pH 7.0) with 0.1% Tween 20 to a
ﬁnal concentration of 4.5 lM that contain 20% glycerol and split into
two matched black-walled quartz cuvets (1 ml). After running a base
line, 1 ll of JM-8686 (1 mM dissolved in Me2SO) was added to the
sample cuvet, and equal volumes of Me2SO were added to the refer-
ence cuvet. The samples were kept for 2 min to equilibrate, and the dif-
ference spectrum was then run between 340 and 540 nm. The ﬁnal
volume of additions was kept to <1% of the total volume. Changes
in absorbance as a function of JM-8686 concentration (1, 2, 3, 4, 6,
8 lM), at wavelengths selected on the basis of the spectral characteris-
tics of the individual sample, were used to calculate binding constants
based on linear regression analysis. Spectral determinations were per-
formed at least twice for each experiment and found to be reproducible
with respect to the spectral proﬁle and the position of kmax and kmin.2.9. Kinetic analysis
For kinetic analysis, the concentration of 13 (S) HPOT was varied
from 20 to 120 lM. The concentration of JM-8686 was varied from
0.1 to 0.8 lM. The concentration of AtAOS was ﬁxed at 5 nM. The ini-
tial velocity of the decrease in absorption at 235 nm was followed for
10–30 s, depending on the initial concentration of 13 (S) HPOT. The
data were ﬁtted to non-linear regression to the Michaelis–Menten
equation, using a program of Enzyme Kinetics Module (Version 1.1,
SPSS Inc. Chicago, IL).3. Results
3.1. Inhibition of AOS activity by JM-8686
In our previous study, we showed that JM-8686 potently
inhibited AtAOS activity in a dose-dependent manner [18].
Here, we measured the inhibitory activity of JM-8686 against
puriﬁed recombinant AtAOS by varying the inhibitor/enzyme
ratio in a ﬁxed concentration of AtAOS (5 nM) and 13 (S)
HPOT (4 lM). As shown in Fig. 2, for the [JM-8686]/[AOS]
Fig. 2. Stoichiometry of JM-8686 binding to AtAOS. The puriﬁed
recombinant AtAOS (5 nM) was pre-incubated with 0–30 nM of JM-
8686 in 50 mM NaH2PO4(pH 7.0) contain 0.1% Tween 20 for 2 min in
a total volume of 3 ml at 25 C. The enzyme reaction was initiated by
adding substrate 13 (S) HPOT in a ﬁnal concentration of 4 lM. The
time course was recorded for 400 s. Inhibition activity of JM-8686 was
calculated from the decreasing of absorbance at 235 nm. All the
experiments were carried out for three times independently.
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increased linearly. The [JM-8686] required to inhibit AtAOS
activity by 50% at 4.5 ± 0.3-fold of [AOS], extrapolating to a
100% inhibition at 9.5 ± 0.2-fold. These results suggest that
JM-8686 is a potent inhibitor of AtAOS.Fig. 3. Steady-state kinetic analysis of the inhibition ofAtAOS by JM-8686.
JM-8686 was carried out by incubation 13 (S) HPOT (120 lM) with 0 lM inh
(h), 0.8 lM inhibitor (j) in 50 mMNaH2PO4 (pH 7.0) with 0.1% Tween 20. T
was recorded for 400 s. The initial rate is shown in the inset. (B) Initial rates w
HPOT (from 20 to 120 lM) and inhibitor as described above. The data at eac
Michaelis–Menten equation to obtain values of Km and kcat. (C) Lineweaver3.2. Steady-state kinetic analysis of the inhibition of AtAOS
by JM-8686
The mechanism of inhibition was investigated further by
analyzing the kinetics under multiple turnover conditions. A
continuous record of the dehydration process of substrates
was determined. Experiments were performed under multiple
turnover (steady state) conditions, i.e., with the concentration
of JM-8686 (0.1–0.8 lM) well below the concentration of 13
(S) HPOT (20–120 lM).
Fig. 3 shows the progress curve of dehydration of 13 (S)
HPOT (initial concentration of 120 lM) by AtAOS (5 nM)
in the absence or presence of varying concentration of JM-
8686 (0.1–0.8 lM). The initial progress curve from 0 to 30 s
is shown in the inset.
To measure the values of Km and kcat, initial rates of dehy-
dration of 13 (S) HPOT were measured by varying both the
concentration of 13 (S) HPOT (from 20 to120 lM) and JM-
8686 (from 0.1 to 0.8 lM). The data obtained at each con-
centration of JM-8686 (as shown in Fig. 3B) were ﬁtted by
non-linear regression to the Michaelis–Menten equation. The
kinetic constants are shown in Table 1. The approximate Km
value for AtAOS was 64.9 ± 15.5 lM. The kcat value was
approximately 72.6 ± 7.9 s1. The Ki value for JM-8686 was
approximately 0.62 ± 0.15 lM.
The pattern of inhibition displayed in the Lineweaver–Burk
double-reciprocal plot (Fig. 3C) was typical for that of com-
petitive inhibition. In this case, there is no change in the Vmax(A) Progress curve analysis for the inhibition of the AtAOS activity by
ibitor (d), 0.1 lM inhibitor (s), 0.3 lM inhibitor (m), 0.6 lM inhibitor
he enzyme reaction was initiated by adding the enzyme. Progress curve
ere determined from progress curve by varying concentrations of 13 (S)
h concentration of JM-8686 were ﬁtted by non-linear regression to the
–Burk replot of the same data showing the ﬁts obtained.
Table 1
Kinetic parameters for inhibition of AtAOS by JM-8686
Km (lM)
a 64.9 ± 15.5
kcat (s
1)a 72 ± 7.9
Ki (lM)
a 0.6 ± 0.1
Kd (lM)
b 1.6 ± 0.2
aKinetic constants of Km, kcat for the recombinant AtAOS and Ki for
JM-8686 were calculated from the data shown in Fig. 3.
bKd was calculated from the data shown in Fig. 4.
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with increasing concentration of JM-8686.
3.3. Reversibility of AtAOS inactivation by JM-8686
To determine whether the inhibitory eﬀect of JM-8686 on
AtAOS inactivation was reversible, AtAOS (15 nM) was
incubated with 5 lM of JM-8686 in a reaction mixture
containing 10 lM 13 (S) HPOT, and the inhibitory activity
of JM-8686 was determined. As shown in Table 2, the activity
of AtAOS was signiﬁcantly decreased to approximately
10 ± 3% of control values obtained in the presence of inhibi-
tor. After overnight dialysis, the activity of AtAOS was
completely restored, indicating a selective reversion of JM-
8686 inhibition.Table 2
Reversibility of AOS inhibition by JM-8686
AOS activity (%)a
Before dialysis After dialysis
Control 100 ± 2 100 ± 2
JM-8686 (5 lM) 10 ± 3 96 ± 3
aAtAOS (5 nM) was added to an enzyme reaction mixture (50 mM
NaH2PO4 (pH 7.0) with 0.1% Tween 20 and 13 (S) HPOT (10 lM)), in
the absence (closed bar) and presence (5 lM) JM-8686. Measurement
of AOS activity and dialysis of enzyme-inhibitor mixture is as de-
scribed under Section 2. This experiment was done for three times to
establish the repeatability.
Fig. 4. Binding of JM-8686 to AtAOS. (A) Absorption spectra of oxidized A
AtAOS (4.5 lM) was dissolved in 50 mM NaH2PO4 (pH 7.0) with 0.1% Twe
ﬁnal concentration of 8 lM. (B) Spectrophotometric titration of AtAOS with
AtAOS (4.5 lM) at various ﬁnal concentrations (a, 1; b, 2; c, 3; d, 4; e, 6; f, 8
reciprocal plot of absorbance diﬀerences, DA (433–409 nm) versus the JM-83.4. Binding of JM-8686 to AtAOS
Binding of JM-8686 to AtAOS was determined by measur-
ing the optical diﬀerence spectra upon addition of JM-8686
to recombinant AtAOS. AtAOS exhibited a Soret absorption
peak at 419 nm, which is characteristic of low-spin P450s
(Fig. 4A, solid line). The addition of JM-8686 to AtAOS in-
duced a type II absorbance shift of the heme Soret band from
419 to 423 nm (Fig. 4A, broken line), which is the characteris-
tic of the formation of a low spin heme–imidazole complex.
This behavior is usually associated with the direct coordination
of the imidazole group of JM-8686 to the heme iron of AtAOS
[20]. The dissociation constant (Kd) was determined by titrat-
ing the observed spectral absorbance diﬀerence DA (433–
409 nm) versus the concentration of inhibitor (Fig. 4B, inset).
The Kd for JM-8686 was approximately 1.6 ± 0.2 lM.
3.5. Selectivity of AtAOS inactivation by JM-8686
AtAOS is a member of a family (CYP74s) of cytochrome
P-450s that are specialized for the metabolism of fatty acid
hydroperoxides. Also included in this family of P450s are
hydroperoxide lyase (HPL, CYP74B and C) and divinylether
synthase (DES, CYP74D) [21]. In contrast to P450 monooxy-
genases that require molecular oxygen and NADPH-depen-
dent cytochrome P450 reductase for activity, AOS and HPL
utilize an acyl hydroperoxide both as the oxygen donor and
as the substrate in which the new carbon–oxygen bonds are
formed. In addition, both AOS and HPL utilize the same sub-
strate (13 (S) HPOT) [22]. We thus used HPL (CYP74B) rom
tomato to test the selectivity of JM-8686 inhibition. As shown
in Fig. 5, AtAOS activity was reduced to 8 ± 1% in the pres-
ence of 5 lM JM-8686, whereas under the same experimental
conditions, JM-8686 inhibited HPL activity only slightly. This
result indicates that JM-8686 is a selective inhibitor of AtAOS.4. Discussion
In the present study, we used a variety of biochemical means
to demonstrate that JM-8686 is a potent and speciﬁc inhibitortAOS (solid line) and its JM-8686 complex (broken line). Recombinant
en 20 containing 20% glycerol, and JM-8686 was added to AtAOS at a
JM-8686 induced spectral changes in AtAOS. JM-8686 was added to
lM). The spectral dissociation constant was calculated from a double
686 concentrations given 1.6 ± 0.2 lM (inset).
Fig. 5. Comparison the inhibitory activity of JM-8686 against LeHPL
and AtAOS by JM-8686. Progress curve analysis for the inhibition of
the LeHPL activity by JM-8686 was carried out by incubation of 13 (S)
HPOT (80 lM) with 0 lM inhibitor (s), 1 lM inhibitor (j), 3 lM
inhibitor (r), 5 lM inhibitor (n). The enzyme reaction was initiated
by adding LeHPL to a ﬁnal concentration of 5 nM. The negative
control for JM-8686 to inhibit AtAOS (d) was carried out by
incubation 5 lM of JM-8686 with 80 lM 13 (S) HPOT and 5 nM
AtAOS. Other experimental details are same as Fig. 3A. Data were
shown as plots from average of three independent experiments.
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tion suggests that JM-8686 is a highly potent inhibitor of this
enzyme (Fig. 2). Second, steady-state kinetic analysis suggests
that JM-8686 is a competitive inhibitor of AtAOS, with a Ki
value approximately 0.62 ± 0.15 lM (Fig. 3). Inhibition of
AtAOS by JM-8686 is reversible in dialysis experiments (Table
2), indicating that enzyme inhibition is not caused by a non-
speciﬁc eﬀect or irreversible damage of AtAOS. Third, analysis
of the binding of JM-8686 to AtAOS provided evidence that
JM-8686 induces a type II binding spectra that is characteristic
of direct coordination of the imidazole group of the inhibitor
to the heme iron (Fig. 4). The binding dissociation constant
was estimated to be 1.6 ± 0.2 lM. Finally, we used HPL from
tomato to test the selectivity of JM-8686. Although both AOS
and HPL belong to the same family of P450 (CYP74A for
AOS, CYP74B for HPL), and they share the same substrate
[22], 13 (S) HPOT, the inhibitory activities of JM-8686 to these
two enzymes are quite diﬀerent (Fig. 5). JM-8686 at a concen-
tration of 5 lM inhibited approximately 90% of AtAOS activ-
ity. Under the same conditions, however, JM-8686 inhibited
less than 10% of the HPL activity. This result suggests that
JM-8686 is a highly selective inhibitor of AtAOS.
AOS (CYP74A) belongs to a unique class of P450s that use a
hydroperoxide group both as the oxygen donor and as a
source of reducing equivalents [22]. On the basis of this infor-
mation we designed and synthesized a chemical inhibitor of
AOS [18]. The data presented in this study support the validity
of the strategy used to design JM-8686. We chose a long single
chain structure containing a carboxylic acid moiety to mimic
the partial structure of linolenic acid. Simultaneously, we
introduced an imidazole group into the inhibitor that mimics
the hydroperoxy group of 13 (S) HPOT for heme coordina-
tion. As shown in Fig. 4, JM-8686 induced a typical type II
binding spectra, indicating a direct interaction of inhibitor
and enzyme at the prosthetic heme iron located in the catalyticreaction center. Data obtained from kinetic analysis also indi-
cate that JM-8686 acts as a competitive inhibitor that binds to
the active site of AtAOS.
Data obtained from the dialysis experiments indicate that
inhibition of AtAOS by JM-8686 is reversible. In experiments
aimed at determining whether the inactivation of AtAOS by
JM-8686 is time dependent, we found that there was no eﬀect
of a 30 min pre-incubation of AOS with the inhibitor (data not
shown). This ﬁnding indicates that binding of JM-8686 to
AtAOS does not irreversibly inactivate the enzyme. In addi-
tion, the reversible formation of inhibitor–enzyme complex
suggests that JM-8686 selectively binds to the free AtAOS
rather than to the enzyme–substrate complex.
One question raised by our results is why JM-8686 exhibits
apparent selectivity for AOS over HPL. As indicated in previ-
ous studies of HPL from tea and soybean, the carboxyl group
of the HPL substrates is important for HPL-substrate recogni-
tion. Chemical modiﬁcation of the carboxyl group greatly
inﬂuences the catalytic activity of HPL [23]. Additional struc-
tural requirements of HPL substrates are the cis, trans-conju-
gated diene system with the trans double bond [24]. Given
the chemical structure of JM-8686, we suggest that the heptyl
ester moiety of the inhibitor may reduce the inhibitory potency
of JM-8686 against HPL. It is also possible that the binding
pocket of HPL prevents entrance of the inhibitor to the active
site of HPL. Chemical modiﬁcation of the carboxyl moiety of
JM-8686 may be useful for design of new inhibitors that are
selective for these enzymes. To our knowledge, JM-8686 is
the ﬁrst example of a synthetic inhibitor that is speciﬁc for jas-
monic acid branch of oxylipin metabolism. We expect further
chemical studies on the development of new AOS inhibitors
may provide useful tools in dissecting JA-related signal trans-
duction networks.
Recent work from Asami et al. has demonstrated the power
of the use of a speciﬁc inhibitor of brassinosteroid biosynthe-
sis. They showed that brassinazole, a fully synthetic derivative,
targets the DWF4 cytochrome P450 monooxygenase that is in-
volved in brassinosteroid biosynthesis [25]. Brassinazole has
been widely used for brassinosteroid research, both for the elu-
cidation of brassinosteroid function in plant physiology and
the identiﬁcation of brassinosteroid signal transduction com-
ponents [26]. The use of chemicals in genetic screens for novel
signaling mutants has emerged as a useful way to study biolog-
ical systems in plants [27]. Such approaches provide a means to
complement classical biochemical and genetic methods. Spe-
ciﬁc inhibitors of AOS may provide useful tools to further dis-
sect the jasmonate biosynthesis and signaling pathways.
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